Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Neratinib
Nerlynx (neratinib) received FDA approval on July 17, 2017.
That approval date refers to the initial FDA approval of Nerlynx for its labeled use. If you’re looking for a later supplemental indication or label expansion (which would have its own FDA action date), tell me which indication you mean (for example, early-stage extended adjuvant therapy vs. metastatic settings), and I can help pinpoint that specific approval/action date.
Other Questions About Neratinib :